TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.

Ecaterina E Dumbrava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.